PPT-Treatment regimens

Author : mitsue-stanley | Published Date : 2017-01-21

Coformulated ombitasvir OBV paritaprevir PTV rironavir r 25150100 mg QD 2 tablets Dasabuvir DSV 250 mg bid Objective SVR 12 HCV RNA lt 25 IUml TURQUOISEIII

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Treatment regimens" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Treatment regimens: Transcript


Coformulated ombitasvir OBV paritaprevir PTV rironavir r 25150100 mg QD 2 tablets Dasabuvir DSV 250 mg bid Objective SVR 12 HCV RNA lt 25 IUml TURQUOISEIII . KGMU. Top five states in India which have highest number of leprosy cases. State 2009-10 2010-11 2011-12 2012-13. Uttar Pradesh 27,473 25,509 24,627 24,222. 500,000 cases annually of MDR TB. Second line treatment toxic and weak. 15% of TB is HIV-related. Drug-drug interactions problematic. 15% of TB is in children. Formulations inadequate, dosages poorly understood. Co-formulated . ombitasvir. (OBV)/. paritaprevir. (PTV)/. rironavir. (r) :. 25/150/100 mg QD = 2 tablets. Dasabuvir. (DSV) : 250 mg bid. Objective. SVR. 12. (HCV RNA < 25 IU/ml). TURQUOISE-III . Susan M. Graham . Assistant Professor, Medicine and Global Health. Adjunct Assistant Professor, Epidemiology. Presentation prepared by: . Susan M. Graham. Last Updated: . October 29, 2014. Susan M. Graham, MD MPH PhD. KGMU. Top five states in India which have highest number of leprosy cases. State 2009-10 2010-11 2011-12 2012-13. Uttar Pradesh 27,473 25,509 24,627 24,222. Learning Objectives. Understand when to switch to a second-line regimen. Know preferred second-line regimens for adults (including pregnant and breastfeeding women), adolescents, and children. Describe common drug resistance mutations and how they influence choosing a second-line regimen. * Not his real name. Munya*. In December. HIV negative. Active TB. TB disease for Munya. What??!! . But how?. What will people say?. Will I die?. Treatment for how long?. Will it work?. TB Treatment Shortening Regimens &. This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. 1 Ju ne 2019 The New Standard Provider FAQ Early diagnosis of HIV infection, followed by prompt antiretroviral therapy ( ART ) initiation , expands the concept of universal ART . There are cle Zevalin, supplied as kit for radiopharmaceutical preparation for intravenous use, contains four components, all the non-radioactive ingredients necessary to produce a single dose of 90Y] ZEVALIN. 1 WHAT DOES IT MEAN?. 6. 6. 4. 4. 1. 1. x24. x24. one-month or once weekly treatment regimens for . TB prevention. . . four-month treatment regimens for drug-sensitive TB.  . six-month treatment regimens for . Anastasiya Nestsiarovich, MD, PhD. Postdoctoral Fellow. University of New . Mexico Health Sciences Center. Department of Internal . Medicine. Center . for Global . Health. September 16, 2019. Research team:. and . Virologic. Outcomes . for Treatment-experienced . People Living with HIV Switching to MTR or STR ART since 2018 . Ben Chastek. 1. , Amy Anderson. 1. , Joshua Gruber. 2. , Sunil Majethia. 2. , Woodie Zachry. R. egimens . m. ay Need . O. ptimization for Youth Failing ART. V Kouamou. , J Manasa, D Katzenstein, A McGregor, CE Ndhlovu, A T Makadzange, PESU Study Team. C. onflict . of . Interest . D. eclaration.

Download Document

Here is the link to download the presentation.
"Treatment regimens"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents